Company profilePharmaceutical#2 of 1,318 in Pakistan5 DRAP alerts

BIO LABS (PVT) LTD.

Pharmaceutical company · 614 brands · 417 molecules

Ranked #6 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

614 registered products 81 pharmaceutical brands 417 distinct molecules 5 DRAP alerts

Company overview

614
registered products
81
pharmaceutical brands
417
distinct molecules
12
therapeutic classes
5
DRAP alerts

BIO LABS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 614 product registrations across 417 distinct molecules. It is the 2nd largest registrant in Pakistan by product count, and ranks 6th of 213 in Other Beta-Lactam, Cephalosporins & Penems. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Antiinflammatory And Antirheumatic Products. DRAP has issued 5 alerts involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by BIO

276 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2
Antiinflammatory And Antirheumatic Products 2

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

260
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202568
2026192

Top molecules by brand count

Nutritional Supplement / Multivitamin117 brands
Betamethasone13 brands
Ondansetron8 brands
Omeprazole7 brands
Quetiapine6 brands
Azithromycin6 brands
Folic Acid6 brands

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 14Antiinflammatory And Antirheumatic Products · 11Antianemic, Iron Preparations · 8Quinolone Antibacterials · 8Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 7Antiemetics & Antinauseants · 7Antidepressants · 5Vitamin A, D & Combinations · 5Psycholeptics; Antipsychotics, Anxiolytics, Hypnotics And Sedatives · 5Macrolides, Lincosamides And Streptogramins · 4Opioids · 4Antimycotics Systemic Use · 4

Conditions treated

Conventional Agents · 1Fungal Infection · 1Migraine/Vertigo · 1Neuropathic Pain/Epilepsy/Convulsion · 1General Infections · 1Eczema/Psoriasis/Dermatitis · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official380 products · Rs 3.78 – Rs 57,079.82
DVAGO6 products · Rs 145.32 – Rs 475
Servaid9 products · Rs 120 – Rs 500
Median across source: Rs 350

Regulatory record

5 alerts in the DRAP feed we track.

Recall Alert; Drug Products: Mebzole 100mg/5mL Suspension and Bioris 1mg/ml Oral Solution
2024-04-29
Recall Alert; Drug Products: Artecid 75mg/3mL Injections by M/s Biolabs Pvt., Ltd., Islama
2024-04-28
Rapid Alert: Contaminated Glycerin (Batch # 1A2192K) Allegedly Produced By M/S KLM Palm Ol
2024-02-05
The National Pharmacovigilance Center, DRAP urge the manufacturers and importers to nomina
2023-08-23
Drug Product Recall: Biofen Suspension (Batch # SP-67) by M/S. Bio-Labs Private Limited, I
2021-10-26

Competitive set

Companies whose registered portfolio overlaps most with this one.

NEUTRO PHARMA (PVT) LTD.133 shared molecules
VALOR PHARMACEUTICALS114 shared molecules
HIGH - Q INTERNATIONAL113 shared molecules
Genix Pharma Private Limited113 shared molecules

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

NABIQASIM INDUSTRIES (PVT) LTD. holds 132 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
GETZ PHARMA PAKISTAN (PVT) LTD. holds 205 molecules not in this portfolio
),Formoterol3 ) 20Mg} Folic AcidAcetazolamideAcyclovirAdrenalineAlbendazole
NEUTRO PHARMA (PVT) LTD. holds 77 molecules not in this portfolio
AcetylcysteineAcyclovirAlbendazoleAmikacinAnastrazoleAnastrozole

Get the full profile for BIO

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.